Results 121 to 130 of about 321,377 (388)

Antifouling Surface‐Attached Hydrogel Nanocoatings Redefined: Green Solvent‐Based, Degradable, and High‐Performance Protection Against Foulants

open access: yesAdvanced Materials Interfaces, EarlyView.
An ultrathin surface‐attached hydrogel coating is introduced that, unlike the best antifouling coatings so far, consists of hydrophilic, non‐charged, green solvent‐based monomers. It effectively renders the surfaces of medical devices stealth toward proteins, a clinical strain of MRSA and blood while offering on‐demand degradability to regenerate the ...
Jenny Englert   +7 more
wiley   +1 more source

Left Atrial Thrombus Causing Stroke and Syncope: Does Size Matters?

open access: yesHeart India, 2014
Left atrium thrombus is seen in patients with rheumatic heart disease, severe mitral stenosis and/or atrial fibrillation, but is usually immobile and located in left atrial appendage.
Surender Deora   +3 more
doaj   +1 more source

Thrombus in transit

open access: yesCardiovascular Medicine, 2018
Extension from the right atrium through the aortic valve via entrapment in a patent foramen ...
Karan Bhatti   +4 more
openaire   +2 more sources

Thrombus Migration and Fragmentation After Intravenous Alteplase Treatment

open access: yesStroke, 2020
Supplemental Digital Content is available in the text. Background and Purpose: There is interest in what happens over time to the thrombus after intravenous alteplase.
T. Ohara   +24 more
semanticscholar   +1 more source

Global Thrombosis Test - a possible monitoring system for the effects and safety of dabigatran [PDF]

open access: yes, 2015
© Otsui et al. 2015BACKGROUND: Dabigatran is an alternative to warfarin (WF) for the thromboprophylaxis of stroke in patients with non-valvular atrial fibrillation (NVAF). The advantage of dabigatran over WF is that monitoring is not required; however, a
Gorog, Diana A   +8 more
core   +1 more source

Surface Engineering of Thrombus‐Targeting Nanocarriers for Cardiovascular Diseases: A Short Review

open access: yesAdvanced Materials Interfaces, EarlyView.
This paper systematically introduces surface modification strategies for thrombus‐targeting nanocarriers, highlights the clinical significance of nanocarrier‐based thrombolysis therapies, and prospects the synergy of combing thrombolysis and anti‐inflammatory therapies for enhanced therapeutic effect.
Xinyue Ge   +7 more
wiley   +1 more source

Relationship Between C-Reactive Protein to Albumin Ratio and Thrombus Burden in Patients With Acute Coronary Syndrome

open access: yesClinical and applied thrombosis/hemostasis, 2019
Increased coronary thrombus burden is known to be a strong predictor of adverse cardiovascular (CV) outcomes. C-reactive protein to albumin ratio (CAR) can be used as a surrogate marker of pro-inflammation which is closely related to prothrombotic state.
H. Duman   +7 more
semanticscholar   +1 more source

Wilms Tumour with Intracardiac Extension. [PDF]

open access: yes, 2012
Wilms tumour or nephroblastoma is the most common renal tumour of in children. It accounts for 6% of all pediatric tumours and is the second most frequent intrabdominal solid organ tumour in children.
Appaji, L, Kumari, AB, Srivatsa, KS
core  

Portal Venous Thrombosis Associated with Use of Etonogestrel/ethinyl Estradiol Vaginal Ring [PDF]

open access: yes, 2020
Introduction: Portal venous thrombosis is a life-threatening cause of abdominal pain. In younger patients, heritable thrombophilias, pregnancy, tobacco use, and oral contraceptives are associated.Case Report: A 26-year-old woman prescribed contraceptive ...
Bailey, Katelynn E.   +1 more
core  

Incomplete Resolution of Deep Vein Thromboses during Rivaroxaban Therapy. [PDF]

open access: yes, 2017
We present the case of a patient with a deep vein thrombosis (DVT) who failed rivaroxaban therapy. Our patient initially presented with left lower extremity edema, erythema, and pain.
Adashek, Jacob   +6 more
core   +5 more sources

Home - About - Disclaimer - Privacy